Evidence map›Paper›PMID 18366637›Full record

ArticleBMC microbiology2008

Characterisation of Shiga toxin-producing Escherichia coli O157 strains isolated from humans in Argentina, Australia and New Zealand.

Gerardo A Leotta, Elizabeth S Miliwebsky, Isabel Chinen, Estela M Espinosa, Kristy Azzopardi, Sharon M Tennant, Roy M Robins-Browne, Marta Rivas

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Shiga toxin-producing Escherichia coli in beef retail markets from Argentina.Frontiers in cellular and infection microbiology · 2012
    Article
  19. Article
  20. Shiga toxin-producing Escherichia coli (STEC).Clinics in laboratory medicine · 2010
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Gerardo A LeottaServicio Fisiopatogenia, Instituto Nacional de Enfermedades Infecciosas - ANLIS Dr. Carlos G. Malbrán. Av. Vélez Sarsfield 563 (1281) Ciudad Autónoma de Buenos Aires, Argentina.galeotta@anlis.gov.ar
Elizabeth S Miliwebsky
Isabel Chinen
Estela M Espinosa
Kristy Azzopardi
Sharon M Tennant
Roy M Robins-Browne
Marta Rivas
Administración Nacional de Laboratorios e Institutos de Salud · ARRoyal Children's Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundShiga toxin-producing Escherichia coli (STEC) is an important cause of bloody diarrhoea (BD), non-bloody diarrhoea (NBD) and the haemolytic uraemic syndrome (HUS). In Argentina and New Zealand, the most prevalent STEC serotype is O157:H7, which is responsible for the majority of HUS cases. In Australia, on the other hand, STEC O157:H7 is associated with a minority of HUS cases. The main aims of this study were to compare the phenotypic and genotypic characteristics of STEC O157 strains isolated between 1993 and 1996 from humans in Argentina, Australia and New Zealand, and to establish their clonal relatedness.

resultsSeventy-three O157 STEC strains, isolated from HUS (n = 36), BD (n = 20), NBD (n = 10), or unspecified conditions (n = 7) in Argentina, Australia and New Zealand, were analysed. The strains were confirmed to be E. coli O157 by biochemical tests and serotyping. A multiplex polymerase chain reaction (PCR) was used to amplify the stx1, stx2 and rfbO157 genes and a genotyping method based on PCR-RFLP was used to determine stx1 and stx2 variants. This analysis revealed that the most frequent stx genotypes were stx2/stx2c (vh-a) (91%) in Argentina, stx2 (89%) in New Zealand, and stx1/stx2 (30%) in Australia. No stx1-postive strains were identified in Argentina or New Zealand. All strains harboured the eae gene and 72 strains produced enterohaemolysin (EHEC-Hly). The clonal relatedness of strains was investigated by phage typing and pulsed-field gel electrophoresis (PFGE). The most frequent phage types (PT) identified in Argentinian, Australian, and New Zealand strains were PT49 (n = 12), PT14 (n = 9), and PT2 (n = 15), respectively. Forty-six different patterns were obtained by XbaI-PFGE; 37 strains were grouped in 10 clusters and 36 strains showed unique patterns. Most clusters could be further subdivided by BlnI-PFGE.

conclusionSTEC O157 strains isolated in Argentina, Australia, and New Zealand differed from each other in terms of stx-genotype and phage type. Additionally, no common PFGE patterns were found in strains isolated in the three countries. International collaborative studies of the type reported here are needed to detect and monitor potentially hypervirulent STEC clones.

Indexed as

Adhesins, BacterialArgentinaAustraliaBacterial ProteinsBacterial Typing TechniquesBacteriophage TypingCluster AnalysisDNA, BacterialDNA FingerprintingElectrophoresis, Gel, Pulsed-FieldEscherichia coli InfectionsEscherichia coli O157Escherichia coli ProteinsGenotypeHemolysin ProteinsHemolytic-Uremic SyndromeAdhesins, BacterialBacterial ProteinsDNA, BacterialeaeA protein, E colienterohemolysinEscherichia coli ProteinsHemolysin Proteinsrfb protein, BacteriaShiga Toxin 1Shiga Toxin 2

Identifiers

PMID18366637
PMCPMC2277424
OpenAlexW2051000559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.